Scientists from The Institute of Cancer Research (ICR) have discovered 13 new genetic errors related with an increased risk of developing glioma in one of the largest ever studies of this devastating disease

On Sunday 26 March, the House of Lords Select Committee on Charities published a report, ‘Stronger charities for a stronger society’, following an inquiry into issues facing the charity sector in England and Wales.

A team of researchers from Northwestern University, USA have identified a molecule that could be used to inhibit the growth of the most fatal paediatric brain tumour, diffuse pontine intrinsic glioma (DIPG).

Over the last three years, The Brain Tumour Charity has expressed concerns about the assessment criteria used for Personal Independence Payments (PIPs), and their impact on people affected by a brain tumour.

Many news outlets are today reporting concerns from medical research institutions that childhood cancer patients in the UK will miss out on access to clinical trials for new treatments following Brexit.

Dr Thomas Ward, part of the Leeds Institute of Cancer and Pathology research team, is funded by various cancer charities including The Brain Tumour Charity.

Cameron Miller, our Information & Support Services Manager, outlines the growing trend for crowdfunding for treatment funds.

Findings from a study published in the International Journal of Nanomedicine have shown for the first time that the drug Panobinostat can be encapsulated in a water soluble molecule and delivered to a brain tumour to destroy high grade glioma cells.

Senior Policy and Public Affairs Manager, Beccy Shortt, discusses the journey many women face to being correctly diagnosed with a brain tumour.

A new, promising clinical trial, led by Dr Stephen Price, is opening in the UK to look at how using advanced imaging methods can predict where a glioblastoma tumour is likely to grow back before any treatment is given. This study is the first of its kind to better understand this question.

Researcher and clinicians at King’s College Hospital in London are trialling a Virtual Reality (VR) app to help children due to undergo an MRI (magnetic resonance imaging).

In the largest study of its kind, researchers found that advanced precision medicine has beneficial applications for treating childhood brain tumours.

Fleur Latter’s sister Grace, was diagnosed with a pilocytic astrocytoma in early 2014 when she was in her third year at University.

Earlier this week, positive results were released from a clinical study testing a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) as a treatment in recurrent glioblastoma (GBM) patients in the UK.

Researchers at the University of Adelaide have developed a novel piece of technology that acts as a tiny flashlight, allowing surgeons to see in to the brain. This machinery could transform neurosurgery for both patients and doctors.

BBC Children in Need and St James’s Place Foundation have awarded grants totalling over £208,000 to The Brain Tumour Charity’s support services.

On Monday The Brain Tumour Charity attended the second meeting of the task and finish working group on research into brain tumour (TFWG) which was set up by the Department of Health to address barriers to research.

Policy Officer, James Thorneycroft, discusses how leaving the EU could affect research into brain tumours.

The cause behind millions of cases of food poisoning has been surprisingly effective in crossing the blood brain barrier to reach tumour sites. Researchers at Duke University genetically modified the bacteria Salmonella to enable it to seek out and attack glioblastoma tumour cells in animal models.

Scientists at the University of Leeds have discovered that targeting a protein that helps cancer cells repair their DNA could lead to a new treatment for the highly aggressive brain tumour, glioblastoma (GBM).

Claire Lloyd came across our HeadSmart website, which lists the most common signs of childhood brain tumours, after her nine-year-old son Jack had been vomiting regularly during the day for more than a week.

David Jenkinson, Chief Scientific Officer at The Brain Tumour Charity, discusses laying foundations for more effective brain tumour treatments.

HeadSmart has already helped cut the average diagnosis time for a childhood brain tumour in the UK from more than 13 weeks to 6.5 weeks.

A combinatorial approach using immunotherapy and gene therapy has been explored by researchers at the University of Michigan against the highly aggressive brain tumour, glioblastoma (GBM).